These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1311437)

  • 1. [Efficacy and tolerance of dideoxynucleosides in HIV infection].
    Molina JM
    Pathol Biol (Paris); 1992 Nov; 39(9):877-8. PubMed ID: 1311437
    [No Abstract]   [Full Text] [Related]  

  • 2. New developments in dideoxynucleoside antiretroviral therapy for HIV infection.
    Fischl MA
    AIDS Clin Rev; 1991; ():197-214. PubMed ID: 1651100
    [No Abstract]   [Full Text] [Related]  

  • 3. [AIDS: small, life-prolonging steps. Antiviral therapy is more efficient--a decrease in side effects].
    Mahler W
    Fortschr Med; 1989 Sep; 107(26):18-9. PubMed ID: 2553564
    [No Abstract]   [Full Text] [Related]  

  • 4. [HIV infection. Zidovudine and 2',3'-dideoxycytidine in AIDS].
    Walz B
    Med Monatsschr Pharm; 1988 Dec; 11(12):415. PubMed ID: 2850454
    [No Abstract]   [Full Text] [Related]  

  • 5. AIDS: AZT for children in extended US trial.
    Lindley D
    Nature; 1989 Nov; 342(6245):10. PubMed ID: 2811993
    [No Abstract]   [Full Text] [Related]  

  • 6. [AIDS: combination drug partner for AZT. HIV infection--new nucleoside analog].
    Böttger S
    Fortschr Med; 1994 Oct; 112(30):50. PubMed ID: 7806121
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trials of combination therapies for HIV infection. Rationale for development of multidrug therapy.
    Hoth D
    J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 2():S95-6. PubMed ID: 2172506
    [No Abstract]   [Full Text] [Related]  

  • 8. Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.
    Moyle GJ; Bouza E; Antunes F; Smith D; Harris R; Warburg M; Walker M
    Antivir Ther; 1997 Dec; 2(4):229-36. PubMed ID: 11327442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retrovir].
    Vesterdal A
    Sygeplejersken; 1989 Jun; 89(23):18. PubMed ID: 2763113
    [No Abstract]   [Full Text] [Related]  

  • 10. [AZT therapy. Success in HIV-infected children].
    Marcus U
    Fortschr Med; 1989 Jan; 107(3):9-10. PubMed ID: 2920990
    [No Abstract]   [Full Text] [Related]  

  • 11. [Another AIDS drug. Azidothymidine--dideoxycytidine].
    Moosmann EB
    Fortschr Med; 1992 Jun; 110(18):28-30. PubMed ID: 1353746
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatments of human immunodeficiency virus infection. Current developments].
    Sereni D; Rousseau F
    Ann Med Interne (Paris); 1991; 142(3):209-14. PubMed ID: 1649566
    [No Abstract]   [Full Text] [Related]  

  • 13. [The acquired immunodeficiency syndrome (AIDS) in childhood].
    Terragna A; Ferrazin A; Gotta C; Wenda-Ciravegna B
    Medicina (Firenze); 1990; 10(3):256-62. PubMed ID: 1964193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of HIV disease in 1993/1994.
    Fischl MA
    AIDS Clin Rev; 1993-1994; ():167-87. PubMed ID: 8217898
    [No Abstract]   [Full Text] [Related]  

  • 15. 3TC approval may revive AZT's appeal.
    Vazquez E
    Posit Aware; 1996; 7(1):8-9. PubMed ID: 11363136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of ethanol and Marinol/marijuana usage on HIV+/AIDS patients undergoing azidothymidine, azidothymidine/dideoxycytidine, or dideoxyinosine therapy.
    Whitfield RM; Bechtel LM; Starich GH
    Alcohol Clin Exp Res; 1997 Feb; 21(1):122-7. PubMed ID: 9046384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dideoxycytidine (ddC): a potent antiretroviral agent for human immunodeficiency virus infection. An introduction.
    Broder S
    Am J Med; 1990 May; 88(5B):1S. PubMed ID: 2159701
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary study analysis suggests similar efficacy for didanosine and zalcitabine.
    Clin Pharm; 1993 Jun; 12(6):391, 395. PubMed ID: 8403811
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-HIV therapy (1987-1994): from nothing to confusion].
    Lissen E
    Med Clin (Barc); 1995 Apr; 104(12):463-7. PubMed ID: 7739285
    [No Abstract]   [Full Text] [Related]  

  • 20. [The anti-viral agents used in the treatment of AIDS].
    Portet-Brunet L
    Soins; 1994 May; (584):55-7. PubMed ID: 8029731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.